You Are Here:Home/Resources/details
National Partnership to Improve Dementia Care in Nursing Homes: Antipsychotic Medication Use Data Report (January 2018):
CMS is tracking the progress of the National Partnership by reviewing publicly reported measures. The official measure of the Partnership is the percentage of long-stay nursing home residents who are receiving an antipsychotic medication, excluding those residents diagnosed with schizophrenia, Huntington's Disease or Tourette’s Syndrome. In 2011Q4, 23.9 percent of long-stay nursing home residents were receiving an antipsychotic medication; since then there has been a decrease of 35.4 percent to a national prevalence of 15.4 percent in 2017Q3. Success has varied by state and CMS region, with some states and regions having seen a reduction of greater than 35 percent.
To access this article, please login or sign up for a membership.